Accueil   Diary - News   All news ERYTECH Appoints Allene M. Diaz to its Board of Directors

ERYTECH Appoints Allene M. Diaz to its Board of Directors

Logo ERYTECH JPEG

ERYTECH Pharma (Euronext Paris:ERYP) (Paris:ERYP) (ADR:EYRYY), a French biopharmaceutical company developing ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, today announced the appointment of Allene M. Diaz to its Board of Directors as a nonvoting member (censeur). As censeur, Ms. Diaz will initially attend all Board of Directors meetings in an advisory capacity.

 

ERYTECH intends to nominate her to serve as a voting Board member in January 2017 in anticipation to the next general shareholders’ meeting. Ms. Diaz has more than 20 years of experience in the global biopharmaceutical and biotechnology industry and has held management and executive positions at leading biopharmaceutical companies, including TESARO, Merck Serono, Biogen Idec and Pfizer.





Read the press release